Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Keßler

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmaceutics|November 26, 2022
Leveraging Dissolution by Autoinjector DesignsChristoph Spangardt, Christoph Keßler, Ramona Dobrzewski, et al.
Advanced Drug Delivery Reviews|March 21, 2026
From canes to pills: the evolution of carbon monoxide therapeuticsFiona Halbig, Simon Reiländer, Christoph Keßler, et al.
Molecular Pharmaceutics|October 31, 2023
Bile Is a Selective Elevator for Mucosal Mechanics and TransportSimon Hanio, Stephanie Möllmert, Conrad Möckel, et al.
Nature Communications|February 14, 2026
Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxiaBenita Menden, Rana D Incebacak Eltemur, German Demidov, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmaceutics|November 26, 2022
Leveraging Dissolution by Autoinjector DesignsChristoph Spangardt, Christoph Keßler, Ramona Dobrzewski, et al.
Advanced Drug Delivery Reviews|March 21, 2026
From canes to pills: the evolution of carbon monoxide therapeuticsFiona Halbig, Simon Reiländer, Christoph Keßler, et al.
Molecular Pharmaceutics|October 31, 2023
Bile Is a Selective Elevator for Mucosal Mechanics and TransportSimon Hanio, Stephanie Möllmert, Conrad Möckel, et al.
Nature Communications|February 14, 2026
Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxiaBenita Menden, Rana D Incebacak Eltemur, German Demidov, et al.
Pageof 1